The regulation of CCR2 on B cells in the pathogenesis of SLE needs further study, finding targeted drugs from corresponding signalling pathways deserves to take a place in the treatment of autoimmune diseases. The gene discussed is CCR2; the disease is systemic lupus erythematosus.